Skip to main content

Table 1 Clinical characteristics of the genotyped subjects in the ISOR study

From: The TCF7L2rs7903146 polymorphism, dietary intakes and type 2 diabetes risk in an Algerian population

Parameter

Non-T2D subjects

T2D subjects

p

 

(n = 644)

(n = 76)

 

Age (years)

42.8 ± 9.6

52.0 ± 9.5

9.4 × 10−15

Weight (kg)

70.6 ± 14.6

75.6 ± 13.9

0.005

BMI (kg/m2)

25.8 ± 5.1

27.9 ± 5.2

0.001

Waist (cm)

86.4 ± 12.2

95.6 ± 10.9

5.8 × 10−10

Hip (cm)

101.7 ± 9.7

102.5 ± 11.0

0.53

Waist-to-hip ratio

0.85 ± 0.08

0.94 ± 0.11

9.0 × 10−17

Fasting glucose (mmol/L)

4.78 ± 0.49

9.58 ± 3.02

5.71 × 10−176

Fasting insulin (μIU/mL)

7.94 ± 5.67

11.34 ± 10.70

0.002

HOMA-IR

1.7 ± 1.2

4.7 ± 5.2

4.5 × 10−25

HOMA-B

144.7 ± 130.3

51.8 ± 55.9

6.8 × 10−37

Triglycerides (mmol/L)

1.11 ± 0.47

1.58 ± 0.70

4.4 × 10−11

Total cholesterol (mmol/L)

4.44 ± 0.90

4.54 ± 1.03

0.33

HDL-cholesterol (mmol/L)

1.26 ± 0.31

1.21 ± 0.30

0.17

LDL-cholesterol (mmol/L)

2.68 ± 0.85

2.67 ± 1.03

0.92

SBP (mmHg)

122.1 ± 17.2

133.6 ± 22.2

6.3 × 10−8

DBP (mmHg)

76.2 ± 9.9

81.1 ± 9.2

4.5 × 10−5

  1. Data are expressed as the mean ± standard deviation.